Peter Welch actually said...

"There ought to be transparency--transparency on the rebates and, I think, transparency on how much is really spent on R&D."

"Solving this drug-pricing crisis will require a multifaceted approach that addresses the misaligned incentives throughout the supply chain that often encourage gaming and lead to higher costs."

"All of us have a concern about a formulary. Is that going to restrict patient access?"

"I don't see that as R&D."